// you’re reading...

Diabetes Treatment

Lyxumia, Sanofi’s Type 2 Diabetes Treatment, Approved in EU

By ⋅ February 4, 2013 ⋅ Email This Post Email This Post ⋅ Print This Post Print This Post ⋅ Post a comment


Economic Times

Lyxumia, Sanofi's Type 2 Diabetes Treatment, Approved in EU
A Sweet Life (blog)
Lyxumia is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) for the treatment of patients with type 2 diabetes mellitus. GLP-1 is a naturally-occurring peptide hormone that is released within minutes after eating a meal. It is known to suppress …
Sanofi's diabetes drug Lyxumia approved in EuropeEconomic Times
Sanofi Gets Marketing Authorization For Lyxumia in EuropeFox Business

all 4 news articles »

More details can be found at www.diabeteshowto.com

Discussion

Comments are disallowed for this post.

Comments are closed.

Tag Cloud

DIABETES Diabetes Symptoms Diabetes Treatment DIET EXERCISE GESTATIONAL Gestational Diabetes glucose tolerance test Juvenile Diabetes TYPE 2

Most Emailed